ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,745.37
      0.40%
      US Tech 100
      19,532.40
      -0.24%
      Dow Jones
      42,175.11
      0.62%
      Brent Oil
      71.315
      0.51%
      Bitcoin
      65,739.63
      0.85%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. 10x Genomics Inc (TXG)

      7. 10x Genomics Inc (TXG) News

      TXG

      10x Genomics (TXG)

      10x Genomics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TXG
      DateTimeSourceHeadlineSymbolCompany
      09/10/20249:00AMPR Newswire (US)Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain CancerNASDAQ:TXG10x Genomics Inc
      09/04/20245:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      09/03/20244:05PMPR Newswire (US)10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell ResearchNASDAQ:TXG10x Genomics Inc
      08/26/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      08/26/20245:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      08/26/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      08/22/20248:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      08/22/20248:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      08/22/20248:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      08/22/20244:05PMPR Newswire (US)10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:TXG10x Genomics Inc
      08/20/20244:35PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      08/08/20244:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TXG10x Genomics Inc
      08/08/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
      08/08/20244:05PMPR Newswire (US)10x Genomics Announces Senior Leadership ChangesNASDAQ:TXG10x Genomics Inc
      08/08/20244:04PMPR Newswire (US)10x Genomics Reports Second Quarter 2024 Financial ResultsNASDAQ:TXG10x Genomics Inc
      08/05/20244:00PMPR Newswire (US)10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex DiseasesNASDAQ:TXG10x Genomics Inc
      07/19/20244:42PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      07/12/20248:00AMPR Newswire (US)10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:TXG10x Genomics Inc
      07/11/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
      07/11/20246:17AMIH Market NewsCostco Hikes Membership Fees; ON Semiconductor Stock Drops 3%; WD-40 Soars 13% on Strong Q3 EarningsNASDAQ:TXG10x Genomics Inc
      06/27/20249:00AMPR Newswire (US)New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial TechnologiesNASDAQ:TXG10x Genomics Inc
      06/20/20249:00AMPR Newswire (US)10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways PanelNASDAQ:TXG10x Genomics Inc
      06/13/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
      06/06/20244:13PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TXG10x Genomics Inc
      05/31/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      05/29/20244:05PMPR Newswire (US)10x Genomics Launches 5,000-Plex Gene Panel for XeniumNASDAQ:TXG10x Genomics Inc
      05/23/20247:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      05/23/20247:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      05/23/20247:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      05/22/20244:27PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
       Showing the most relevant articles for your search:NASDAQ:TXG